A retrospective-prospective, observational, multicenter, open-label study of effects of 12 months of rhPTH in patients with chronic hypoparathyroidism
Latest Information Update: 27 Apr 2022
At a glance
- Drugs Parathyroid hormone (Primary)
- Indications Hypoparathyroidism
- Focus Therapeutic Use
Most Recent Events
- 27 Apr 2022 New trial record
- 23 Apr 2022 Results published in the Journal of Endocrinological Investigation